biomedicina slovenica


pr=Čufer : 282-381

  1. Ovčariček T; Triller N; Sadikov A; Čufer T
    Prognostic value of C-reactive protein in patients with advanced non-small cell lung cancer
    2009
  2. Karina M; Čufer Tanja
    Preliminary safety data of the EORTC 10994/BIG 00-01 neoadjuvant trial comparing 3 cycles of docetaxel followed by 3 cycles of epirubicin-docetaxel versus 6 cycles of FEC 100 in patients with locally advanced/inflammatory or large operable breast cancer
    2006
  3. Golouh Rastko; Čufer Tanja; Sadikov A; Nusdorfer P; Usher P; Bruenner N; Schmitt M; Harbeck N; Lesche R; Meier S
    Stathmin-1 protein expression is associated with disease recurrence in tamoxifen-treated steroid hormone receptor positive early breast cancer: an immunohistochemical study
    2006
  4. Čufer Tanja
    Drugo mnenje, obveznost ali želja
    2008
  5. Čufer Tanja
    Novosti v sistemskem zdravljenju raka dojk z aeomatiziranimi inhibitorji in biološkimi zdravili
    2009
  6. Čufer Tanja
    Zdravljenje solidnih rakov z biološkimi zdravili v Sloveniji
    2009
  7. Lampret Tadeja; Čufer Tanja; Fras Albert-Peter; Marušič Dorjan
    Kdo je komu v napoto: sprti zdravniki na Onkološkem inštitutu
    2003
  8. Čufer Tanja; Dal Lago Lissandra; Demonty Gaston; Piccart Martine; Puglisi Fabio
    HER2 (neu) and trastuzumab (Herceptin) - paradigm of a targeted therapy
    2006
  9. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant anastrozole or tamoxifen in breast cancer: #a #Slovenian perspective
    2006
  10. Colleoni M; Li SZ; Gelber Richard D; Coates Alan S; Castiglione-Gertsch M; Price Karen; Lindtner Jurij; Rudenstam Carl-Magnus; Crivellari Diana; Collins Joseph; Pagani Olivia; Simoncini E.; Thürlimann Beat; Murray Elizabeth; Forbes John Alexander; Eržen Darja; Holmberg Stig B.; Veronesi A.; Goldhirsch Aron; Plesničar Andrej; Majdič Elga; Štabuc Borut; Golouh Rastko; Lamovec Janez; Jančar Janez; Vrhovec Ivan; Kramberger Marta; Novak Janez; Naglas M; Senčar Mojca; Červek Jožica; Šebek Slava; Cerar Olga; Čufer Tanja
    Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer
    2005
  11. Bokal Ljudmila; Gregori Janez; Grajzar Franc; Mihelič Janez; Majdič Viktor; Hočevar Janez; Atelšek Simon; Debelak Marjan; Humar Marjeta; Starman Bernarda; Čufer Andrejka; Grajzar Franc
    Čebelarski terminološki slovar
    2008
  12. Ribnikar D; Fink Š; Frković-Grazio S; Lešničar H; Sadikov A; Čufer T
    Potek bolezni pri bolnicah s HER-2 pozitivnim rakom dojk
    2008
  13. Buturović-Ponikvar J; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Hemodialysis in Slovenia - data from Slovenian RRT registry 2006
    2008
  14. Buturović-Ponikvar Jadranka; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj-Lopert Simona; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rukavina Nikola; Rus Igor; Saksida Silvan; Vujkovac Bojan
    Slovenian renal replacement therapy registry: 2006 annual report
    2008
  15. Buturović-Ponikvar J; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Hemodialysis in Slovenia - data from the Slovenian renal replacement therapy registry 2006
    2008
  16. Sušnik Dragica; Uršič-Vrščaj Marjetka; Čufer Tanja
    Žensk naj ne bo strah lastnih dojk: "rožnati" oktober
    2005
  17. Čufer Tanja; Lorenčič Mojca
    Včasih je dobro biti poskusni zajček
    2006
  18. Čufer Tanja; Šimenc Mojca
    Bolnic z rakom dojke bo v naslednjem desetletju še več
    2005
  19. Virant Igor; Sonc Monika; Čufer Tanja
    Farmakologija protitumornih učinkovin s poudarkom na interakcijah
    2006
  20. Lahajnar Slavica; Čufer Tanja
    Vprašanja in odgovori
    2006
  21. Borštnar Simona; Čufer Tanja
    Zdravljenje hormonsko neodvisnega raka prostate
    2006
  22. Čufer Tanja
    Intervju s prof. dr. Marijo Us-Krašovec: strokovnjakinjo, znanstvenico in pedagoginjo, idejno materjo časopisa Onkologija
    2006
  23. Hočevar Marko; Vakselj Aleš; Čufer Tanja; Us Jurij
    Vprašanja in odgovori
    2005
  24. Čufer Tanja; Borštnar Simona; Vrhovec Ivan
    Prognostic and predictive value of the urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in operable breast cancer
    2003
  25. Reberšek Martina; Čufer Tanja; Serša Gregor
    Electrochemotherapy (ECT) with intratumoral application of cisplatin in breast cancer
    2003
  26. Južnič-Šetina Tanja; Čufer Tanja; Borštnar Simona
    Breast cancer in men: a 20 year review of 60 patients in Slovenia
    2003
  27. Čufer Tanja; Pajk Bojana; Borštnar Simona
    Individualised systemic treatment
    2006
  28. Pajk Bojana; Čufer Tanja; Canney Peter; Ellis Paul; Cameron David; Blot Emmanuel; Vermorken Jan; Coleman Robert; Marreaud Sandrine; Bogaerts Jan
    Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from EORTC 10001 randomized phase II trial
    2008
  29. Čufer Tanja
    Pomen kliničnih raziskav v onkologiji
    2008
  30. Vojaković Ksenija; Čufer Tanja
    3. dan internistične onkologije, oktober 2007
    2008
  31. Bizjak-Ogrinc Urška; Čufer Tanja; Pompe-Kirn Vera
    Survival of patients with invasive urinary bladder cancer in Slovenia regarding to stage of disease and treatment in years 1987-1997
    2007
  32. Buturović-Ponikvar J; Adamlje T; Blamuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lapert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Hemodialysis in Slovenia
    2008
  33. Ravnik Maja; Takač Iztok; Arko Darja; Gorišek Borut; Čas-Sikošek Nina; Lampelj Maja; Ravnik Janez; Čufer Tanja
    Expression of invasive markers (uPA/PAI-1) in four different HER2, ER, PR subgroups of early breast cancer
    2008
  34. Lahajnar Slavica; Krčevski-Škvarč Nevenka; Stepanović Aleksander; Čufer Tanja
    Usmeritve za zdravljenje bolečine pri odraslem bolniku z rakom
    [Guidance for cancer pain treatment in adult patients]
    2008
  35. Zielinski Christoph C.; Awada Ahmad; Cameron David A.; Čufer Tanja; Martin Miguel; Aapro Matti S.
    The impact of new European organisation for research and treatment of cancer guidelines on the use of granulocyte colony-stimulating factor on the management of breast cancer patients
    2008
  36. Čufer Tanja
    Reducing the risk of late recurrence in hormone-responsive breast cancer
    2007
  37. Snoj Nataša; Čufer Tanja
    Biološko in tarčno zdravljenje karcinomov
    2007
  38. Matos Erika; Čufer Tanja; Žgajnar Janez; Bračko Matej; Takač Iztok
    Lastnosti tumorja in zdravljenje
    2007
  39. Čufer Tanja
    Rak prostate
    2006
  40. Čufer Tanja
    Sistemsko zdravljenje raka: dejstva in pričakovanja
    2007
  41. Cataliotti L.; Čufer Tanja
    Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
    2007
  42. Čufer Tanja
    New standards in the chemotherapy of breast cancer
    2006
  43. Čufer Tanja
    Sistemsko zdraveljenje raka: dejstva in pričakovanja
    [Systemic theapy of cancer: facts and expectations]
    2007
  44. Matos Erika; Čufer Tanja
    Adjuvant treatment of breast cancer patients with trastuzumab
    [Dopolnilno zdravljenje bolnic z rakom dojke s transtuzumabom]
    2007
  45. Borštnar Simona; Čufer Tanja; Kmetec Andrej; Kragelj Borut; Ovčak Zdenka; Sedmak Boris; Milakić-Snoj Zvezdana; Volavšek Metka; Primic-Žakelj Maja
    Rak prostate: kaj morate vedeti
    2007
  46. Čufer T
    The advantages and shortages of academic research in Europe
    2007
  47. Ravnik M; Arko D; Žagar T; Primic-Žakelj M; Čufer T
    Breast cancer and second malignancies
    2007
  48. Matos E; Čufer T
    The role of trastuzumab in the adjuvant setting
    2007
  49. Čufer T
    The role of chemotherapy in early breast cancer patients
    2007
  50. Morales Leilani; Čufer Tanja
    Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer : a randomised phase III trial of the European Organis[!]ation for Research and Treatment of Cancer Breast Group
    2007
  51. Buturović-Ponikvar Jadranka; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Vascular access in chronic hemodialysis patients in Slovenia: data from the Slovenian renal replacement therapy registry, annual report 2005
    2007
  52. Borštnar Simona; Pajk Bojana; Bernot Marjana; Čufer Tanja; Horvat Marika; Mlakar-Mastnak Denis; Ocvirk janja; Sonc Monika; Umičevič Snežana; Uršič-Vrščaj Marjetka; Zajc Metka; Zakotnik Branko
    Napotki za premagovanje neželenih učinkov sistemskega zdravljenja raka
    2007
  53. Čufer Tanja; Pajk Bojana
    Sistemska terapija rakave bolezni in njen vpliv na bolnika
    2007
  54. Čufer Tanja
    Biološko zdravljenje karcinomov
    [Update on the biological therapy of carcinomas]
    2007
  55. Tomažič Janez; Vovk Marjeta; Čufer Tanja; Tomšič Matija; Pretnar Jože
    Okužbe pri zdravljenju z biološkimi zdravili
    [Infections in biological treatment]
    2007
  56. Virant Igor; Sonc Monika; Čufer Tanja
    Farmakologija protitumornih učinkovin s poudarkom na interakcijah
    2007
  57. Čufer Tanja; Snoj Nataša
    Biološka terapija karcinomov
    2007
  58. Matos E; Pajk B; Borštnar S; Čufer T
    Dopolnilno zdravljenje bolnic z rakom dojke s trastuzumabom; trenutno priporočeni izbor zdravljanja na Onkološkem inštitutu v Ljubljani
    2006
  59. Borštnar S; Pajk B; Matos E; Čufer T
    Dopolnilno hormonsko zdravljenje pomenopavznih bolnic s hormonsko odvisnim rakom dojke; trenutno priporočeni izbor zdravljenja na Onkološkem inštitutu v Ljubljani
    2006
  60. Čufer Tanja
    Nova zdravila za boljše obvladovanje raka dojk
    2006
  61. Čufer Tanja; Snoj Nataša
    Algoritmi zdravljenja raka dojke in novosti na tem področju
    [Treatment algorithms for breast cancer and new approaches]
    2006
  62. Globokar T; Snoj Nataša; Sadikov A; Čufer T
    Amenorrhea as a prognostic factor in premenopausal endocrine responsive early breast cancer patients
    2006
  63. Snoj Nataša; Globokar T; Sadikov A; Čufer T
    Correlation between hormonal receptor levels and efficacy of hormonal therapy and chemotherapy in metastatic breast cancer
    2006
  64. Čufer Tanja
    Novo zdravilo?
    2006
  65. Foekens John A; Atkins David; Zhang Yi; Sweep Fred CGJ; Harbeck Nadia; Paradiso Angelo; Čufer Tanja; Sieuwerts Anieta M; Talantov Dmitri; Golouh Rastko
    Multicenter validation of a gene expression-based prognostic signature in lymph node - negative primary breast cancer
    2006
  66. Čufer Tanja
    Sistemsko zdravljenje
    2006
  67. Decock Julie; Paradaens Robert; Čufer Tanja
    Proteases and metastasis: clinical relevance nowadays?
    2005
  68. Čufer Tanja
    Uspešna dopolnilna zdravila
    2005
  69. Kozak Matija; Čufer Tanja
    Presejalne preiskave za odkrivanje raka pri bolnikih z vensko trombozo
    2006
  70. Červek Jožica; Čufer Tanja; Uršič-Vrščaj Marjetka; Zakotnik Branko
    Le ovinek na poti življenja: knjižica za pomoč bolnikom z rakom in njihovim svojcem
    2006
  71. Čufer Tanja
    Chemotherapy in the adjuvant setting: goals and strategies
    2005
  72. Piccart MJ; de Valeriola D; Dal-Lago L; de Azambuja E; Demonty G; Lebrun F; Bernard-Marty Ch; Colozza M; Čufer T
    Adjuvant chemotherapy in 2005: standards and beyond
    2005
  73. Čufer Tanja
    Biology of metastasis with focus on proteases
    2004
  74. Čufer T; Vrdoljak E
    Sign: a Phase II, open-label, randomized study comparing gefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
    2005
  75. Snoj Nataša; Drev Primož; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole and tamoxifen in HER2 positive breast cancer patients
    2005
  76. Ebert Maja; Borštnar Simona; Červek Jožica; Čufer Tanja; Pajk Bojana
    Feasibility and toxicity of adjuvant chemotherapy in breast cancer patients over 70 years old
    2005
  77. Globokar Tina; Borštnar Simona; Čufer Tanja; Pajk Bojana; Červek Jožica
    CNS metastases in breast cancer patients treated with trastuzumab
    2005
  78. Čufer T; Vrdoljak E
    Results from a phase II, open-label, randomized study (SIGN) comparing gefitinib with docetaxel as second-line theraphy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
    2005
  79. Harbeck N; Bohlmann I; Ross JS; Gruetzman R; Kristiansen G; Margossian A; Hartmann A; Čufer T; Paradiso A; Maier S
    Multicenter study validates PITX2 DNA methylation for risk prediction in tamoxifen-treated, none-negative breast cancer using paraffin-embedded tumor tissue
    2005
  80. Lahajnar S; Rotovnik-Kozjek N; Čufer T; Vakselj A
    Vprašanja in odgovori
    2005
  81. Čufer Tanja
    Rak ledvic
    2005
  82. Čufer Tanja
    Rak prostate zbuja novo upanje
    2005
  83. Čufer Tanja
    Palliative and supportive care
    2005
  84. Čufer Tanja
    Hormoni in rak
    2005
  85. Čufer T; Piccart-Gebhart M
    Adjuvant chemotherapy: standards and beyond
    2005
  86. Jagodic M; Vrhovec I; Borštnar S; Čufer T
    Prognostic and predictive value of cathepsins D and L in operable breast cancer patients
    2005
  87. Čufer Tanja
    Clinical relevance of proteases and their inhibitors in breast cancer
    2005
  88. Kragelj Borut; Zaletel-Kragelj Lijana; Sedmak Boris; Čufer Tanja; Červek Jožica
    Phase II study of radiochemotherapy with vinblastine in invasive bladder cancer
    2005
  89. Čufer T
    Citostatsko zdravljenje napredovalega raka prostate
    2005
  90. Čufer Tanja
    Stanje splošne oslabelosti pri bolnikih z rakom
    2005
  91. Čufer Tanja
    Prognoza netipljivih invazivnih rakov dojke
    2004
  92. Borštnar S; Vrhovec I; Čufer T
    High levels of uPA and PAI-1 predicts a good response to antracyclines
    2004
  93. Čufer Tanja
    Rak prostate: nejasnosti in pasti odkrivanja
    2004
  94. Čufer Tanja
    Hormonsko zdravljenje invazivnega raka dojk
    2004
  95. Efficace Fabio; Therasse Patrick; Piccart Martine J; Coens Corneel; van Steen Kristel; Welnicka-Jaskiewicz Marzena; Čufer Tanja; Dyczka Jaroslaw; Lichinitser Michail; Shepherd Lois
    Health-related quality of life parameters as prognostic factors in a nonmestatic breast cancer population: an international multicenter study
    2004
  96. Globokar Tina; Pajk Bojana; Čufer Tanja
    Docetaxel chemotherapy induced amenorrhea in breast cancer patients
    2004
  97. Snoj Nataša; Drev Primož; Pajk Bojana; Borštnar Simona; Golouh Rastko; Čufer Tanja
    The response to treatment with anastrozole in HER2 positive metastatic breast cancer patients
    2004
  98. Piškur Peter; Sonc Monika; Čufer Tanja; Borštnar Simona; Mrhar Aleš
    Pharmacoeconomic aspects of adjuvant early breast cancer (EBC) treatment in postmenopausal women with anastrozole (A) or tamoxifen (T): Slovenian perspective
    2004
  99. Velepič Marina; Čufer Tanja
    Sprejem in bivanje na Onkološkem inštitutu v Ljubljani
    2002
  100. Efficace F; Therasse P; Piccart M; Coens C; Van Steen K; Welnicka-Jaskiewicz M; Čufer T; Lichinitser M; Shepherd L; Bottomley A
    Predicting survival with health-related quality of life scores in locally advanced breast cancer: results from an international randomized controlled trial
    2004

   1 82 182 282 382 482  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics